Salkind GeneDirector
bought UPXI
at $2.55
on 2025-11-20
· return since -72.1% (now $0.71)
Salkind GeneDirector
bought UPXI
at $2.65
on 2025-11-17
· return since -73.1% (now $0.71)
Salkind GeneDirector
bought UPXI
at $2.81
on 2025-11-17
· return since -74.6% (now $0.71)
Anomalous trades (penny price, >±1000% return, wild price ratio, or FX/ADR mismatch) are flagged and excluded from default rankings. Returns floored at −100%.